Low ejection fraction documented during cardiac catheterization is significantly associated with long-term, all-cause mortality

Cardiovascular Revascularization Medicine

Volumn 11, Issue 3, 2010, Pages 163-166

  Movahed, Mohammad Reza ^a   Sattur, Sudhakar ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cardiomypathy; Cardiovascular risk factors; Catheterization; Myocardial infarction; Ventricolography

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; ANGIOCARDIOGRAPHY; ARTICLE; ASIAN; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHI SQUARE TEST; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ETHNICITY; EUROPEAN AMERICAN; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICULOGRAPHY; HISPANIC; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SMOKING; SURVIVAL TIME; UNIVARIATE ANALYSIS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; CORONARY DISEASE; FACTUAL DATABASE; FEMALE; FOLLOW UP; HEART STROKE VOLUME; MALE; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURVIVAL; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 77954295694     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2009.04.110     Document Type: Article

References (14)

1. Cohn JN, et al. Report of the National Heart, Lung, and Blood Institute special emphasis panel on heart failure research. Circulation 1997, 95(4):766-770.
2. Myerburg RJ Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001, 12(3):369-381.
3. Curtis JP, et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 2003, 42(4):736-742.
4. Halkin A, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005, 45(9):1397-1405.
5. Shiga T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era. Results from the HIJAMI-II Registry. Heart 2008.
6. Solomon SD, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005, 112(24):3738-3744.
7. van der Vleuten PA, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord 2008, 8:4.
8. Gosselink AT, et al. Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group. Clin Cardiol 1998, 21(4):254-260.
9. Nunez J, et al. Prognostic value of the left ventricular ejection fraction in patients with acute heart failure. Med Clin (Barc) 2008, 131(5):161-166.
10. Sanz G, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 1982, 306(18):1065-1070.
11. Risk stratification and survival after myocardial infarction. N Engl J Med 1983, 309(6):331-336.
12. Moss AJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346(12):877-883.
13. Khalil ME, et al. A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol 2001, 37(7):1757-1764.
14. Dargie HJ Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001, 357(9266):1385-1390.